105 Residents of Bengaluru Apartment Complex Test Positive for Covid-19 After Attending a Party

At least 105 residents of an apartment complex in Bengaluru’s Bommanahalli have been found to be COVID-19 positive after they attended a party hosted in the complex. The Bruhat Bengaluru Mahanagara Palike (BBMP) began testing the residents after being notified of coronavirus cases on February 12.

The number rose to 105 on Monday, according to BBMP Commissioner Manjunath Prasad. “The number of cases has risen to 105. We are taking all the measures to control further spread of the coronavirus. We have also called a meeting of citizens’ groups of the city to discuss how the spread can be controlled among the people,” Prasad was quoted the The News Minute as saying.

The civic body was going to test 200 more residents on Tuesday. According to Bommanahalli Health Officer Dr Savitha, none the 105 infected residents have shown any symptops of COVID-19 and only one person had to be admitted following a drop in oxygen level. The rest have self-quarantined themselves.

The samples have been sent to NIMHANS (National Institute of Mental Health and Neuro-Sciences) to understand the virulency of the virus and the results are expected to arrive in a week, she said.

“As many as 96 people are above the age of 50, and 68 of these people have comorbidities. We are monitoring the situation,” Dr Savitha said.

The BBMP said it has taken all the necessary measures to prevent the spread of the virus and is also conducting health check-ups in the apartment complex.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’